Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma

Article Information

vol. 44 no. 2 781-786

DOI

PMID

Published By

Print ISSN

0250-7005

Online ISSN

1791-7530

History

¹Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan;
²Department of Urology, Seirei Mikatahara General Hospital, Hamamatsu, Japan;
³Department of Developed Studies for Advanced Robotic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan;
⁴Department of Urology, Hamamatsu Medical Center, Hamamatsu, Japan;
⁵Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan

Correspondence to: Ryo Sato, Department of Urology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka 431-3192, Japan. Tel: +81 534352306, Fax: +81 534352305, e-mail: rsato02{at}hama-med.ac.jp